SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,112,000 | +24.5% | 242,062 | +21.9% | 0.01% | +16.7% |
| Q3 2016 | $4,909,000 | +27.2% | 198,503 | +4.8% | 0.01% | +20.0% |
| Q2 2016 | $3,860,000 | +81.7% | 189,480 | +36.0% | 0.01% | +66.7% |
| Q1 2016 | $2,124,000 | +6.1% | 139,290 | -6.5% | 0.00% | 0.0% |
| Q4 2015 | $2,002,000 | +4.7% | 148,938 | +9.3% | 0.00% | 0.0% |
| Q3 2015 | $1,912,000 | -17.9% | 136,268 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $2,330,000 | +125.6% | 137,239 | +60.6% | 0.00% | +200.0% |
| Q1 2015 | $1,033,000 | +46.5% | 85,470 | +0.6% | 0.00% | 0.0% |
| Q4 2014 | $705,000 | -5.2% | 84,931 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $744,000 | -19.4% | 85,644 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $923,000 | +89.5% | 84,276 | +54.8% | 0.00% | 0.0% |
| Q1 2014 | $487,000 | +46.7% | 54,445 | +23.7% | 0.00% | – |
| Q4 2013 | $332,000 | +7.1% | 44,025 | +4.0% | 0.00% | -100.0% |
| Q3 2013 | $310,000 | +22.5% | 42,331 | +7.7% | 0.00% | – |
| Q2 2013 | $253,000 | – | 39,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |